201 related articles for article (PubMed ID: 23563515)
1. CpG adjuvant enhances the mucosal immunogenicity and efficacy of a Treponema pallidum DNA vaccine in rabbits.
Zhao F; Liu S; Zhang X; Yu J; Zeng T; Gu W; Cao X; Chen X; Wu Y
Hum Vaccin Immunother; 2013 Apr; 9(4):753-60. PubMed ID: 23563515
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.
Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y
Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular primary immunization by nucleic acid vaccine pcDNA/Gpd-IL-2 and enhanced immunization with mucosal adjuvant CpG-ODN and Gpd-IL-2 recombinant protein effectively induced strong mucosal immune responses and immune protective effects against
Zhang X; Zhao T; Zeng T; Wu N; Xiao Y; Liu S; Yu J; Jiang C; Gan L; Deng M; Luo X; Zhao F
Exp Ther Med; 2018 Mar; 15(3):2533-2540. PubMed ID: 29456657
[TBL] [Abstract][Full Text] [Related]
4. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2.
Zhao F; Wu Y; Zhang X; Yu J; Gu W; Liu S; Zeng T; Zhang Y; Wang S
Hum Vaccin; 2011 Oct; 7(10):1083-9. PubMed ID: 21941092
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy against Treponema pallidum in New Zealand rabbits immunized with plasmid DNA encoding flagellin.
Zheng K; Xu M; Xiao Y; Luo H; Xie Y; Yu J; Tan M; Li Y; Zhao F; Zeng T; Wu Y
Emerg Microbes Infect; 2018 Nov; 7(1):177. PubMed ID: 30405111
[TBL] [Abstract][Full Text] [Related]
6. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of
Kataoka K; Kawabata S; Koyanagi K; Hashimoto Y; Miyake T; Fujihashi K
Front Immunol; 2021; 12():634923. PubMed ID: 33717178
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of a Treponema pallidum Gpd DNA vaccine vectored by chitosan nanoparticles and fused with interleukin-2.
Zhao F; Wang S; Zhang X; Gu W; Yu J; Liu S; Zeng T; Zhang Y; Wu Y
Can J Microbiol; 2012 Feb; 58(2):117-23. PubMed ID: 22260167
[TBL] [Abstract][Full Text] [Related]
8. Development of a subunit vaccine containing recombinant Riemerella anatipestifer outer membrane protein A and CpG ODN adjuvant.
Chu CY; Liu CH; Liou JJ; Lee JW; Cheng LT
Vaccine; 2015 Jan; 33(1):92-9. PubMed ID: 25448104
[TBL] [Abstract][Full Text] [Related]
9. [Cloning and expression of outer membrane protein gene Gpd from Treponema pallidum and preliminary studies on its immunogenicity in rabbits].
Zhao FJ; Wu YM; Zhang XH; Liu SQ; Yu MJ
Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):767-71. PubMed ID: 16342773
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant.
Kodama S; Abe N; Hirano T; Suzuki M
Laryngoscope; 2006 Feb; 116(2):331-5. PubMed ID: 16467729
[TBL] [Abstract][Full Text] [Related]
11. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.
Jiang W; Baker HJ; Smith BF
Infect Immun; 2003 Jan; 71(1):40-6. PubMed ID: 12496147
[TBL] [Abstract][Full Text] [Related]
13. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.
Abe N; Kodama S; Hirano T; Eto M; Suzuki M
Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899
[TBL] [Abstract][Full Text] [Related]
14. Intranasal administration of peptide antigens of HIV with mucosal adjuvant CpG ODN coentrapped in microparticles enhances the mucosal and systemic immune responses.
Pun PB; Bhat AA; Mohan T; Kulkarni S; Paranjape R; Rao DN
Int Immunopharmacol; 2009 Apr; 9(4):468-77. PubMed ID: 19291836
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: Dry powder formulation for nasal immunization in rabbits.
Dehghan S; Kheiri MT; Abnous K; Eskandari M; Tafaghodi M
Microb Pathog; 2018 Feb; 115():74-85. PubMed ID: 29223454
[TBL] [Abstract][Full Text] [Related]
16. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
[TBL] [Abstract][Full Text] [Related]
17. CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations.
Van der Stede Y; Verdonck F; Vancaeneghem S; Cox E; Goddeeris BM
Vet Immunol Immunopathol; 2002 May; 86(1-2):31-41. PubMed ID: 11943328
[TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo.
Zhang L; Tian X; Zhou F
Int Immunopharmacol; 2007 Dec; 7(13):1732-40. PubMed ID: 17996683
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
[TBL] [Abstract][Full Text] [Related]
20. Effects of different CpG oligodeoxynucleotides with inactivated avian H5N1 influenza virus on mucosal immunity of chickens.
Fu J; Liang J; Kang H; Lin J; Yu Q; Yang Q
Poult Sci; 2013 Nov; 92(11):2866-75. PubMed ID: 24135589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
